To include your compound in the COVID-19 Resource Center, submit it here.

Avexa discontinues apricitabine

Avexa Ltd. (ASX:AVX) plans to reduce headcount and pursue strategic alternatives after discontinuing development of HIV candidate

Read the full 174 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE